Dimensional Fund Advisors LP lifted its position in AptarGroup, Inc. (NYSE:ATR) by 2.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 619,630 shares of the industrial products company’s stock after purchasing an additional 12,035 shares during the quarter. Dimensional Fund Advisors LP owned 0.99% of AptarGroup worth $53,482,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Schwab Charles Investment Management Inc. boosted its holdings in AptarGroup by 5.0% during the 3rd quarter. Schwab Charles Investment Management Inc. now owns 404,839 shares of the industrial products company’s stock valued at $34,942,000 after acquiring an additional 19,275 shares during the period. Chemical Bank purchased a new stake in AptarGroup during the 2nd quarter valued at about $313,000. Rhumbline Advisers boosted its holdings in AptarGroup by 6.3% during the 3rd quarter. Rhumbline Advisers now owns 165,333 shares of the industrial products company’s stock valued at $14,270,000 after acquiring an additional 9,810 shares during the period. Nicholas Company Inc. boosted its holdings in AptarGroup by 1.0% during the 2nd quarter. Nicholas Company Inc. now owns 594,775 shares of the industrial products company’s stock valued at $51,662,000 after acquiring an additional 5,840 shares during the period. Finally, Wells Fargo & Company MN boosted its holdings in AptarGroup by 2.0% during the 2nd quarter. Wells Fargo & Company MN now owns 702,142 shares of the industrial products company’s stock valued at $60,988,000 after acquiring an additional 13,908 shares during the period. Hedge funds and other institutional investors own 90.97% of the company’s stock.
In other news, Director Ralf K. Wunderlich sold 26,000 shares of the stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $87.03, for a total value of $2,262,780.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Robert Kuhn sold 5,000 shares of the stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $87.43, for a total value of $437,150.00. The disclosure for this sale can be found here. Insiders have sold a total of 77,910 shares of company stock valued at $6,745,469 in the last ninety days. 5.30% of the stock is currently owned by corporate insiders.
AptarGroup, Inc. (NYSE:ATR) opened at $88.61 on Friday. The company has a market capitalization of $5,520.00, a P/E ratio of 25.99, a price-to-earnings-growth ratio of 2.87 and a beta of 0.95. The company has a current ratio of 2.75, a quick ratio of 2.29 and a debt-to-equity ratio of 0.96. AptarGroup, Inc. has a 52-week low of $71.44 and a 52-week high of $90.79.
AptarGroup (NYSE:ATR) last released its quarterly earnings results on Thursday, October 26th. The industrial products company reported $0.83 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.03. The business had revenue of $624.33 million during the quarter, compared to analyst estimates of $599.31 million. AptarGroup had a return on equity of 16.82% and a net margin of 9.24%. AptarGroup’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.82 EPS. equities research analysts forecast that AptarGroup, Inc. will post 3.35 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 21st. Shareholders of record on Wednesday, January 31st will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 1.44%. AptarGroup’s payout ratio is 37.54%.
AptarGroup, Inc is a provider of a range of packaging, dispensing and sealing solutions, primarily for the beauty, personal care, homecare, prescription drug, consumer healthcare, injectables, food and beverage markets. The Company has manufacturing facilities located throughout the world, including North America, Europe, Asia and South America.
Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.